| Financial Year |
March 31 2023 |
| Monetary Funds |
228,648,100.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
199,417,921.78 |
| Advances to Suppliers |
106,470,538.12 |
| Other Receivables |
5,522,123.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
50,352,719.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,671,354.50 |
| Total Current Assets |
612,452,257.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,208,911.74 |
| Investment Properties |
4,659,823.39 |
| Fixed Assetes |
3,504,285,294.79 |
| Under-construction Projects |
262,844,143.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,692,474.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,256,464.15 |
| Deferred Income Tax Assets |
12,897,195.96 |
| Other Non-Current Assets |
1,370,227.88 |
| Sub-Total of Non-Current Assets |
3,956,643,152.62 |
| Total Assets |
4,569,095,410.27 |
| Short-Term Loans |
110,041,291.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
148,035,047.20 |
| Accounts Received In Advance |
3,847,876.00 |
| Employee Compensation Payable |
50,935,689.85 |
| Taxes Payable |
4,737,932.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
178,404,581.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
125,034,046.80 |
| Other Current Liabilities |
15,649,409.50 |
| Sub-Total of Current Liabilities |
1,013,405,712.78 |
| Long-term Loans |
1,914,491,002.87 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
184,290,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,091,057.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,132,885,244.05 |
| Total Liabilities |
3,146,290,956.83 |
| Paid-In Capital(Or Share Stock) |
364,567,500.00 |
| Capital Surplus |
74,080,892.52 |
| Surplus Reserve |
147,632,701.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
592,433,475.68 |
| Minority Stockholder's Interest |
188,864,766.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,233,939,687.41 |
| Owner's Equity（Stockholder's Equity） |
1,422,804,453.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,569,095,410.27 |
